Eli Lilly and Company (LLY)

84.18
NYSE
Prev Close 84.42
Day Low/High 83.86 / 84.98
52 Wk Low/High 64.18 / 86.14
Exchange NYSE
Shares Outstanding 1103.35B
Market Cap 93.15B
Div & Yield N.A. (N.A)

Latest News

Cramer: 3 Health Care Bill Scenarios, 3 Game Plans

Cramer: 3 Health Care Bill Scenarios, 3 Game Plans

Get your plan in place, but understand that the Republic is not in jeopardy.

European Stocks Drift Lower; Deutsche Bank Falls on Rights Issue Details

European Stocks Drift Lower; Deutsche Bank Falls on Rights Issue Details

European stocks drifted lower Monday following a holiday-thinned trading session in Asia as investors prepare for key inflation and private sector activity data later in the week.

European Stocks Set For Mixed Open: Dollar Slumps in Quiet Asia Trade

European Stocks Set For Mixed Open: Dollar Slumps in Quiet Asia Trade

European stocks are expected to open mixed Monday following a holiday-thinned trading session in Asia as investors prepare for key inflation and private sector activity data later in the week.

Dow, S&P 500 Decline as Health Care Losses Counter Gains

Dow, S&P 500 Decline as Health Care Losses Counter Gains

Wall Street ends a jampacked week little changed as a selloff in health care stocks counters broad gains elsewhere.

Fired U.S. Attorney Preet Bharara Was Investigating HHS Chief Tom Price - Report

Fired U.S. Attorney Preet Bharara Was Investigating HHS Chief Tom Price - Report

Fired former U.S. Attorney Preet Bharara was investigating stock trades made by Health and Human Services Secretary Tom Price, according to one report.

Broad Gains Overshadow Health Care Losses to Boost Wall Street

Broad Gains Overshadow Health Care Losses to Boost Wall Street

Stocks rise on Friday even as a selloff in health care extends into its second day.

Stocks Creep Lower as Health Care Selloff Extends Into Day 2

Stocks Creep Lower as Health Care Selloff Extends Into Day 2

Stocks creep lower on Friday as a selloff in health care extends into its second day.

First Dedicated Outcome Trials Of Empagliflozin In Chronic Heart Failure Initiated

First Dedicated Outcome Trials Of Empagliflozin In Chronic Heart Failure Initiated

- EMPEROR HF clinical trial program will evaluate the efficacy and safety of empagliflozin in patients with chronic heart failure, including those with and without type 2 diabetes

When Very Predictable Is Highly Profitable: Cramer's 'Mad Money' Recap (Wednesday 3/15/17)

When Very Predictable Is Highly Profitable: Cramer's 'Mad Money' Recap (Wednesday 3/15/17)

Jim Cramer says economic fundamentals remain strong and this market's rallying with relief at Fed's anticipated rate hike.

Neurotrope Shares Soar as Alzheimer's Drug Trial Lottery Ticket Call Nears

Neurotrope Shares Soar as Alzheimer's Drug Trial Lottery Ticket Call Nears

Despite all the prior failures and blowups, an Alzheimer's drug study -- no matter how unlikely to succeed -- remains an irresistible lure for some investors.

Allergan, Schlumberger, Caterpillar: Doug Kass' Views

Allergan, Schlumberger, Caterpillar: Doug Kass' Views

Doug Kass shares his thoughts on Allergan, and says that Caterpillar remains purr-fect for shorting.

Updates to Indices/Core Holdings and Bullpen; Thanks!

Check out the latest versions of our Investment Indices and Core Holdings as well as 8 Bullpen additions.

Trump's Tweet Creates Opportunity in Pharma: Cramer's 'Mad Money' Recap (Tuesday 2/7/17)

Trump's Tweet Creates Opportunity in Pharma: Cramer's 'Mad Money' Recap (Tuesday 2/7/17)

Jim Cramer says if Trump really wants to lower drug prices, he should target our trading partners.

Eli Lilly: Here's One Drug Company Ready to Rally

Eli Lilly: Here's One Drug Company Ready to Rally

Traders should look to go long on a close above $84.

Cramer: When a Trump Tweet Is a Buy Signal

Cramer: When a Trump Tweet Is a Buy Signal

Drug companies are the latest targets/beneficiaries.

Pharma, Biotech Stocks Fall on Trump Tweets, GOP Health Care Plan

Pharma, Biotech Stocks Fall on Trump Tweets, GOP Health Care Plan

Investors are deciding what to make of an impending overhaul of the American health care system in the wake of legislative progress out of Washington.

Cramer: Top 10 Bull Markets Right Now (Part 1)

Cramer: Top 10 Bull Markets Right Now (Part 1)

Bull market number one, perhaps of all time: the financials.

Cramer: Top 10 Bull Markets Right Now

Cramer: Top 10 Bull Markets Right Now

Bull market number one, perhaps of all time: the financials.

Bull Markets and Drug Rallies: Jim Cramer's Best Blog

Bull Markets and Drug Rallies: Jim Cramer's Best Blog

Jim Cramer ponders the bull market and whether the drug rally is 'Trumped up.'

Eli Lilly Announces Management Changes

Eli Lilly Announces Management Changes

Johna Norton will be replacing Fionnuala Walsh as senior VP of global quality.

Lilly Announces Changes In Senior Management

Lilly Announces Changes In Senior Management

Fionnuala Walsh retiring, Johna Norton promoted; Bart Peterson leaving to pursue external interests

Don't Be Cowed in the Face of This Bull: Cramer's 'Mad Money' Recap (Wednesday March 1)

Don't Be Cowed in the Face of This Bull: Cramer's 'Mad Money' Recap (Wednesday March 1)

Growth is not only about the occupant of the Oval Office, say Jim Cramer. This is a genuine bull market, and it's about how you invest.

Cramer: This Drug Rally Is No Longer 'Trumped Up'

Cramer: This Drug Rally Is No Longer 'Trumped Up'

Let's recognize that some moves are simply related to bonds, which are in the grips of a bizarre developed-world shortage.

Jim Cramer Is Passing on Valeant Ahead of Earnings

Jim Cramer Is Passing on Valeant Ahead of Earnings

Jim Cramer is opting for stocks like Allergan and Johnson & Johnson over Valeant Pharmaceuticals.

What Jim Cramer Expects From Valeant Pharmaceuticals' Results on Tuesday

What Jim Cramer Expects From Valeant Pharmaceuticals' Results on Tuesday

TheStreet's Action Alerts PLUS Portfolio Manager Jim Cramer is keeping an eye on quarterly results from Valeant Pharmaceuticals on Tuesday.